DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Opicinumab
Opicinumab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
Immunfarmakológia Immunfarmakológia
The Two Tontti Tudiul Lui Hi Ha Unit
The Molecular Basis for Remyelination Failure in Multiple Sclerosis
Monoclonal Antibody Therapy in Multiple Sclerosis Finding the Forest Among the Trees with an Update on the Safety, Efficacy, and Mechanisms of Monoclonal Antibodies
Antibodies for the Treatment of Brain Metastases, a Dream Or a Reality?
Monoclonal Antibodies As Neurological Therapeutics
Stembook 2018.Pdf
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
(INN) for Biological and Biotechnological Substances
The Implication of Reticulons (Rtns) in Neurodegenerative Diseases: from Molecular Mechanisms to Potential Diagnostic and Therapeutic Approaches
Strategies to Obtain Diverse and Specific Human Monoclonal
PDF of Antibody News
An Overview of the Current Status of Engineered Therapeutic Monoclonal Antibodies
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
Nogo-A-Antibodies for Progressive Multiple Sclerosis Benjamin V
EFPIA Pipeline Review 2021 Update
Top View
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Biogen Inc. 2020 Annual Report
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
(INN) for Biological and Biotechnological Substances
2018 Medicines in Development for Neurological Disorders a Report on Disorders of the Brain, Spinal Cord and Nerves
Neurology & Neurosurgery
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
WO 2017/189679 Al 02 November 2017 (02.11.2017) W !P O PCT